News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Can losartan delay the progression of AD?
13 Dec 2021
byAudrey Abella
In individuals with clinically diagnosed mild-to-moderate Alzheimer’s disease (AD), treatment with the angiotensin II receptor blocker (ARB) losartan for 12 months did not reduce the rate of brain atrophy, findings from the phase II RADAR* trial suggest.
13 Dec 2021








